Darren Schneider, M.D.

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Darren Schneider, M.D. sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials 1 currently recruiting upper half by trial count

Darren Schneider, M.D.: 1 sponsored US clinical trial, 1 recruiting.

Darren Schneider, M.D. sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Aortic Dissection, Thoracoabdominal, with 1 trials.

Mid-pack sponsor footprint

Darren Schneider, M.D. is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Open and recent trials

1 total, page 1 of 1

RECRUITING NA

Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts

NCT02323581

Therapeutic Areas

Aortic Dissection, Thoracoabdominal 1
Aortic Aneurysm, Thoracic 1
Aortic Aneurysm, Thoracoabdominal 1

What is open in the Darren Schneider, M.D. pipeline

1 recruiting of 1 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Aortic Dissection, Thoracoabdominal (1 trial), 2 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Darren Schneider, M.D.: open-pipeline peers nationwide

Peers matched on 1 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Darren Schneider, M.D. sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 012345 0%50%100%150% Total trials Recruiting share Darren Schneider, M.D.1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO HealthAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
Darren Schneider, M.D. sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Darren Schneider, M.D. sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Darren Schneider, M.D. page

1 registered trials is a research-attention snapshot, not an endorsement of Darren Schneider, M.D. or any single study.

  • 1 of Darren Schneider, M.D.'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Aortic Dissection, Thoracoabdominal is the condition Darren Schneider, M.D. studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aortic Dissection, Thoracoabdominal trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Darren Schneider, M.D. pipeline card: 1 registered trials from official public datasets.Report a data error.